CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,299,668 | +79.4% | 59,856 | +8.1% | 0.00% | +50.0% |
| Q1 2023 | $1,281,561 | -12.4% | 55,359 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $1,462,248 | +38.1% | 55,811 | +3.6% | 0.00% | 0.0% |
| Q3 2022 | $1,059,000 | +15.2% | 53,859 | +2.6% | 0.00% | +100.0% |
| Q2 2022 | $919,000 | +225.9% | 52,517 | +204.6% | 0.00% | – |
| Q1 2022 | $282,000 | -19.0% | 17,241 | -19.1% | 0.00% | – |
| Q4 2021 | $348,000 | +53.3% | 21,308 | +20.0% | 0.00% | – |
| Q3 2021 | $227,000 | -63.0% | 17,762 | -59.1% | 0.00% | -100.0% |
| Q2 2021 | $613,000 | +98.4% | 43,402 | +118.0% | 0.00% | – |
| Q1 2021 | $309,000 | -2.2% | 19,910 | 0.0% | 0.00% | – |
| Q4 2020 | $316,000 | – | 19,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $101,483,000 | 23.66% |
| Octagon Capital Advisors LP | 2,551,703 | $50,166,000 | 8.66% |
| Frazier Life Sciences Management, L.P. | 4,265,559 | $83,861,000 | 6.46% |
| Affinity Asset Advisors, LLC | 813,998 | $16,003,000 | 4.47% |
| Altium Capital Management LP | 525,000 | $10,322,000 | 3.78% |
| Deep Track Capital, LP | 3,000,000 | $58,980,000 | 2.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $6,685,000 | 2.14% |
| Vivo Capital, LLC | 872,151 | $17,146,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 534,358 | $10,505,000 | 1.46% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,240,000 | 1.43% |